A founder in the Middle East does not need one undifferentiated list of wealthy families. The useful shortlist identifies which investing team can consider the company, in its actual market, at the current stage.
These 15 routes include regional family offices, family-origin venture platforms and explicitly labeled family-backed corporate or fund strategies. Specialist cross-border investors are included where their published mandate is relevant. They do not all invest throughout the Gulf, Levant and Israel.
Separate regional roots from investment eligibility
Record four different facts: family or platform origin, investor office, company operations and published investment geography. A Dubai office does not establish Saudi startup eligibility. An Israeli mandate is not automatically a pan-MENA mandate. A global strategy still needs company-specific confirmation.
Check entry stage separately. Pre-seed, seed, pre-Series A and growth are not interchangeable labels, even when the capital comes from an evergreen balance sheet. Keep direct startup equity separate from fund commitments, philanthropy, property and established-business investment.
Compare 15 regional and cross-border family-capital routes
Sources reviewed November 13, 2026. This is a founder research shortlist, not a wealth ranking or a claim that every route accepts companies from every country. Scroll the table horizontally on mobile.
| Investor | Product focus | Stage or route | Geographic filter |
|---|---|---|---|
| AlFardan Ventures | AI, deep tech, health, energy and advanced industry | Early through growth | UAE launchpad, Middle East and global opportunities |
| JIMCO | Biotechnology, healthcare and life-sciences innovation | Early and later life-sciences opportunities; vehicle-specific | Global; confirm relevant company market |
| O.G. Venture Partners | Technology companies | Multi-stage technology investing | Global platform with Israeli roots; team-specific eligibility |
| Arkin Capital | Biotech, digital health and other healthcare strategies | Early and later biotech; digital-health strategies differ | Israel-rooted platform; confirm company eligibility |
| Daher Investments | Diversified private-company opportunities | Direct companies, co-investments and funds; entry stage is deal-specific | Dubai-based global investment activity |
| AMK Investment Office | Private companies and separate fund strategies | Early and later private companies; strategy-specific | Global strategy; London office is not a company restriction |
| Alajlan Family Office | B2B SaaS, future of work, proptech, edtech and developer tools | Mainly pre-seed, seed and pre-Series A | MENAP focus with documented global activity |
| Waad Investment | Technology, fintech, AI, proptech and logistics | Pre-Series A through Series B | GCC and MENA focus |
| Al Faisaliah / Nuwa Capital route | Technology-enabled businesses | Early-stage company equity through the relevant venture strategy | MENA; exact country and vehicle conditions apply |
| CE-Ventures | Consumer, deep tech and biotech; current AI-company investments | Early through later-stage companies | US, MENA, India and Southeast Asia |
| NB Ventures | Diversified technology-enabled companies | Startups through established enterprises; confirm entry stage | GCC and India |
| CPT Capital | Alternative protein, food technology and enabling infrastructure | Pre-seed and seed, with follow-on investing | Global, including Europe and Israel |
| Gloucester Ventures | Biotech tools, platforms and precision diagnostics | Pre-seed and seed | US, UK and Israel |
| SABER | Multi-sector direct startup investment | Private growth companies; precise initial round to confirm | Europe, the US and Israel; Vienna-based |
| Apeiron Investment Group | Transformative technology and human health | Incubation to growth and public holdings; strategy-specific | Global; primary US focus; European teams |
Read provider criteria and approach routes
1. AlFardan Ventures
Family-office and strategic investment arm. AlFardan combines a UAE launchpad with direct company investing across technology and scientific sectors. State the actual company market and stage before discussing regional ambitions. Its family-office identity does not imply that every affiliated platform uses the same investment process.
Founder route: Official Contact form. Official criteria · Supporting official evidence.
2. JIMCO
Jameel-family global investment arm. The Jameel-family investment arm documents global breakthrough-company investing across technology and life sciences. Identify the relevant team and company milestone. Its fund commitments and direct investments are different paths, and the family's regional roots are not a requirement that every company operate in one Gulf country.
Founder route: Official company and investment contact. Official criteria.
3. O.G. Venture Partners
Ofer Global-backed venture platform. O.G. identifies Ofer Global as its single investor, distinguishing the platform from a fund raised from many unrelated LPs. Use its multi-stage technology remit to research the right partner. Confirm country and entry-stage fit before interpreting a global portfolio as a universal invitation.
Founder route: Official investment-team information. Official criteria · Supporting official evidence.
4. Arkin Capital
Family-origin investment platform with external-capital strategies. Arkin's family-origin platform has distinct technology and healthcare investment activities. A biotech company and an enterprise-software company need different teams and evidence. Some current strategies use outside capital, so ask which entity would invest and what decision process applies.
Founder route: Official team and company contact. Official criteria · Supporting official evidence.
5. Daher Investments
Private family office. Daher Investments is the current identity of the platform formerly known as Daher Capital. Its direct deals and fund commitments should be separated in a founder shortlist. A history of backing venture funds does not prove a seed-company application route.
Founder route: Official corporate contact. Official criteria.
6. AMK Investment Office
Second-generation Alkhawaja-family investment office. AMK documents direct-company activity alongside fund investments. The useful first question is which strategy could consider your company, not whether the family has regional assets. Explain the round and target market, then confirm the geographic and stage screen.
Founder route: Official company contact. Official criteria.
7. Alajlan Family Office
Single-family office. Alajlan publishes a mainly pre-seed, seed and pre-Series-A focus, with MENAP as its core region and broader international activity. Its stated priorities include B2B software and developer tools. Use the pitch form to describe the product and team, rather than treating its fund-LP portfolio as extra startup investors.
Founder route: Submit your pitch deck form. Official criteria.
8. Waad Investment
Family-backed investment platform. Waad's published stage range starts later than idea-stage investing. It can be relevant to companies with evidence appropriate to pre-Series A and beyond. Do not confuse Waad with Wa'ed, the separate Aramco-backed investor, or infer a pre-seed mandate from older portfolio material.
Founder route: Official company contact. Official criteria.
9. Al Faisaliah / Nuwa Capital route
Family-business-anchored venture-fund route. Al Faisaliah describes a strategic anchor relationship with Nuwa Capital. This is a family-backed venture route, not a claim that Nuwa is a single-family office. Identify the actual fund and company-investment team; venture debt and fund allocation have different criteria.
Founder route: Official venture-capital business information. Official criteria.
10. CE-Ventures
Corporate venture arm of a family business group. CE-Ventures is the corporate venture arm of Crescent Enterprises within a family business group. Its documented markets include MENA alongside the US, India and Southeast Asia. Separate direct-company investing from its venture-fund portfolio and explain the strategic relevance of the product.
Founder route: Official Crescent Enterprises company contact. Official criteria · Supporting official evidence.
11. NB Ventures
Bhatnagar-family proprietary venture platform. NB Ventures states a GCC-and-India focus and identifies its founder's personal capital as the platform's starting point. That is a useful geographic filter for a founder operating across those markets. Ask for the current company-entry criteria rather than borrow the stage of an older holding.
Founder route: Official Contact Us page. Official criteria · Supporting official evidence · Further official evidence.
12. CPT Capital
Private-family-office venture arm. CPT explicitly includes Israel within a global alternative-protein mandate. It is a specialist cross-border route, not a general Middle East technology investor. A food-materials or enabling-infrastructure company should demonstrate the actual alternative-protein connection and appropriate stage.
Founder route: Published investment-opportunity email. Official criteria.
13. Gloucester Ventures
Single-family office. Gloucester's pre-seed and seed remit explicitly includes Israel alongside the US and UK. Its biotech tools, platforms and diagnostics focus is the important second filter. A regional software company outside that scientific remit does not become eligible merely by sharing a location.
Founder route: Pitch Your Startup on the official site. Official criteria.
14. SABER
Single-family office. SABER's official company profile documents startup and growth-company activity across Europe, the US and Israel. It also invests in venture funds, which are separate from direct-company decisions. No public open-deck form was verified, so use an appropriate team introduction rather than invent an application link.
Founder route: Official company profile; no public deck form verified. Official company profile.
15. Apeiron Investment Group
Founder-owned proprietary investment platform. Apeiron combines global activity with a primary US emphasis and an Abu Dhabi presence. That office is context, not proof of a GCC-wide startup mandate. For a regional opportunity, establish the relevant direct-company strategy and country fit before treating the broader platform as a match.
Founder route: Official contact form. Official criteria.
Build a market screen before asking for an introduction
Write a simple company-market brief: where the company operates, where its customers are, the market it plans to enter and what the next round will finance. Add the actual investing team and one unresolved eligibility question for each provider.
A relevant introduction then has a reason. For example: “We are researching your GCC company strategy for a logistics product already used by regional customers. Is our current stage within the team's mandate?” That is more useful than asking whether the family is interested in startups.
Where can I get investors for my startup?
Start with providers whose current stage, sector and market criteria fit the company. Use the official routes in this directory and the people who genuinely understand the business. A public route or warm introduction can open a conversation, but neither removes the need for fit. Avoid sending the same deck to a family foundation, fund allocator and company-investment team.
A worked shortlist for a regional logistics company
Fictional example: Cedar Routes serves logistics operators in the UAE and Saudi Arabia and is preparing a pre-Series A. The founders investigate Waad's stated stage and regional technology focus, NB Ventures' GCC remit and AlFardan's relevant company-investment areas.
The same team does not include an Israel-specific biotech investor, even though it appears in this regional guide. It also does not treat an Abu Dhabi office as sufficient proof of eligibility. The shortlist records the exact country and product fit before the founders ask for an introduction.
Copy the regional family-capital routing worksheet
Keep each source and open question alongside the investor record in Finta. One clear owner and next step make a regional research list easier to act on.
MIDDLE EAST FAMILY-CAPITAL ROUTING WORKSHEET
Company / product / customer:
Current operations and target markets:
Round and next milestone:
Investor platform and actual company-investing team:
Provider type and source of family-capital connection:
Published geography: GCC / named countries / Israel / global / unknown
Company-country eligibility still to confirm:
Entry stage and sector match:
Direct company equity versus funds, property or philanthropy:
Official approach route / introduction context:
Non-confidential first eligibility question:
Relationship owner / next action / review date:Ask Aurora, Claude or Codex to review your shortlist
Supply your facts and the official sources. Review the result before acting; this is a research aid, not automatic outreach.
Evaluate my Middle East family-capital shortlist using the official sources I provide.
Company facts: [product, customer, actual countries, stage, round and next milestone].
Separate family origin, office location, company operations and documented investment geography. Never imply a fund serves every Gulf, Levant or Israeli market. Distinguish direct company capital from fund allocation, buyouts, property and philanthropy, and identify the actual investing team. Check entry stage and sector independently. Mark unsupported country eligibility unknown. Return a concise research queue with fit reasons, exclusions, open questions and one next action per match. Do not provide restructuring advice, send outreach or promise funding.Methodology and related guides
The Finta Editorial Team reviewed current official strategy, criteria, company, team and contact pages. Each platform counts once, even when it has more than one investment arm. We label family offices, family-origin managers and family-backed corporate or fund routes separately. A portfolio, office or historical fund commitment alone does not establish a current company mandate.
Use the direct-investment family-office hub, family offices versus VC and family-office pitch guide to plan the approach. Keep the seed fundraising comprehensive guide central for the broader raise.
This is general research and organizational information, not financial, legal, tax or jurisdiction-specific eligibility advice. Confirm current country and vehicle conditions directly.